MSNBC Alex Witt Reports February 5, 2022 17:33:00
Has hit a few stumbling blocks. pfizer announced the initial 2 dose regimen for kids 2 to 4 failed to produce enough antibodies against covid. as a result, the company began testing a three-dose regiment which they show to be more effective. pfizer is hope the fda will approve as early as the next couple of weeks, the two dose regimen for now, and they say they are hopeful they will do that which will clear the way for approval of the three-dose regimen later this spring. and we did talk to parents of young children under 5 who may be eligible for the vaccine, and take a listen to what they ha...